Publications in collaboration with researchers from Centro de Investigaciones Biológicas (33)

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  2. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

2022

  1. Spatial Proteomic Analysis of Isogenic Metastatic Colorectal Cancer Cells Reveals Key Dysregulated Proteins Associated with Lymph Node, Liver, and Lung Metastasis

    Cells, Vol. 11, Núm. 3

  2. Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates

    Frontiers in Immunology, Vol. 12

2021

  1. An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity

    Clinical Cancer Research, Vol. 27, Núm. 11, pp. 3167-3177

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Proteomic analysis of low-grade, early-stage endometrial carcinoma reveals new dysregulated pathways associated with cell death and cell signaling

    Cancers, Vol. 13, Núm. 4, pp. 1-16

2020

  1. Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib

    Journal of Pathology, Vol. 252, Núm. 1, pp. 29-40

2018

  1. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

    Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212

2017

  1. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells

    Cancer Letters, Vol. 388, pp. 262-268

  2. Enhanced Missing Proteins Detection in NCI60 Cell Lines Using an Integrative Search Engine Approach

    Journal of Proteome Research, Vol. 16, Núm. 12, pp. 4374-4390

2016

  1. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis

    Proteomics, Vol. 16, Núm. 8, pp. 1280-1290

  2. Evaluation of 10 AMD Associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes

    PLoS ONE, Vol. 11, Núm. 9

  3. Molecular basis of factor H R1210C association with ocular and renal diseases

    Journal of the American Society of Nephrology, Vol. 27, Núm. 5, pp. 1305-1311

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

    Annals of Hematology, Vol. 94, Núm. 3, pp. 379-392

2014

  1. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration

    JAMA Ophthalmology, Vol. 132, Núm. 5, pp. 528-534

2013

  1. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype

    Leukemia, Vol. 27, Núm. 4, pp. 925-931

2012

  1. Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562

    Experimental Biology and Medicine, Vol. 237, Núm. 8, pp. 933-942

  2. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration

    Investigative Ophthalmology and Visual Science, Vol. 53, Núm. 3, pp. 1087-1094